Scientific Background
This trio combines AOD 9604—an hGH-derived fragment studied for fat-metabolism signaling
—with two growth-hormone secretagogues (CJC-1295 No DAC and Ipamorelin). Together, they
create a synergistic metabolic-support and recovery-focused research blend.
Mechanism of Action (Informational Only)

• AOD 9604 interacts with lipolytic pathways
• CJC-1295: GH-axis stimulation via GHRH receptor
• Ipamorelin: selective ghrelin-receptor activation
• May support mitochondrial and metabolic signaling

Potential Functional Benefits

• Interest in fat-loss research
• Supports improved recovery and cellular function
• Often selected for metabolic optimization studies
• May promote healthy GH-axis signaling

Vial Contents

• AOD-9604 6mg
• CJC-1295 No DAC 3mg
• Ipamorelin 3mg

Notes
For research and educational purposes only.